• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

149.66 -9.17 (-5.77%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
What's going on in today's session: S&P500 movers ↗
July 08, 2026
Via Chartmill
Explore the top gainers and losers within the S&P500 index in today's session. ↗
July 08, 2026
Via Chartmill
Gapping S&P500 stocks in Wednesday's session ↗
July 08, 2026
Via Chartmill
Wednesday's pre-market session: top gainers and losers in the S&P500 index ↗
July 08, 2026
Via Chartmill
News headline image
Moderna Appoints Michael McDonnell to Board of Directors
July 08, 2026
From Moderna, Inc.
Via ACCESS Newswire
News headline image
Moderna Stock Is Soaring. Is It Too Late to Buy? ↗
July 07, 2026
Moderna's growth story is just beginning. 
Via The Motley Fool
News headline image
These 3 Stocks Trounced the S&P 500 in the First Half of 2026 -- and Wall Street Thinks 1 of Them Could Soar Even More ↗
July 06, 2026
These stocks have jumped in the double- and triple-digits. 
Via The Motley Fool
Topics Artificial Intelligence Economy Stocks
Stay informed with the top movers within the S&P500 index on Monday. ↗
July 06, 2026
Via Chartmill
Monday's pre-market session: top gainers and losers in the S&P500 index ↗
July 06, 2026
Via Chartmill
Wall Street Got the Weak Jobs Report It Wanted. Chip Stocks Wrecked the Rally Anyway. ↗
July 06, 2026
Via Chartmill
News headline image
MarketBeat Week in Review – 06/29 - 07/03 ↗
July 04, 2026
MarketBeat's weekly roundup covers a weaker June jobs report, tech sector rotation, and top analyst picks including TSLA, AVGO, PLTR, MRNA, and NEE heading into Q2 earnings season. 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Moderna Is Up More Than 70% in a Month After a 9-0 FDA Vote. Wall Street's Average Price Target Says It Should Fall 44%. What Gives? ↗
July 03, 2026
When a stock and the analysts covering it disagree this sharply, one of them is about to be wrong. 
Via The Motley Fool
News headline image
Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026? ↗
July 03, 2026
Moderna expands beyond vaccines while Recursion bets on AI-driven drug discovery, each with distinct risks, partnerships, and financial profiles. 
Via The Motley Fool
News headline image
3 Cash-Heavy Stocks with Warning Signs
July 03, 2026
Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they strugg... 
Via StockStory
Topics Artificial Intelligence
News headline image
Q1 Earnings Highlights: AbbVie (NYSE:ABBV) Vs The Rest Of The Therapeutics Stocks
July 02, 2026
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at AbbVie (NYSE:ABBV) and its pe... 
Via StockStory
Topics Artificial Intelligence
Thursday's session: top gainers and losers in the S&P500 index ↗
July 02, 2026
Via Chartmill
These S&P500 stocks are moving in today's session ↗
July 02, 2026
Via Chartmill
News headline image
Short Squeeze Alert—Moderna Stock Surges on New Strategy ↗
July 01, 2026
Moderna shares rose nearly 20% after Science Day, driven partly by a short squeeze, while its mRNA pipeline beyond vaccines faces a multi-year path to revenue. 
Via MarketBeat
News headline image
Is Moderna Stock a No-Brainer Buy After a Key FDA Win? ↗
June 30, 2026
Moderna's flu vaccine may not fuel a further recovery for the hard-hit COVID-19-affected stock. 
Via The Motley Fool
News headline image
Therapeutics Stocks Q1 Recap: Benchmarking Vertex Pharmaceuticals (NASDAQ:VRTX)
June 29, 2026
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the therapeutics stocks, including Vertex Pharmaceuticals (NASDAQ:VRTX) and its peers. ... 
Via StockStory
Topics Artificial Intelligence
News headline image
Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1
June 29, 2026
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the therapeutics stocks, including Myriad Genetics (NASDAQ:MYGN) and its peers. Over th... 
Via StockStory
Topics Artificial Intelligence
Hormuz Goes Quiet, Software Wakes Up, and Burry Picks a Side ↗
June 29, 2026
Via Chartmill
Discover which S&P500 stocks are making waves on Friday. ↗
June 26, 2026
Via Chartmill
Friday's session: top gainers and losers in the S&P500 index ↗
June 26, 2026
Via Chartmill
News headline image
This Stock Has Already Doubled This Year and Is Still Racing Towards a Major Catalyst ↗
June 26, 2026
It's not just a "pandemic stock," after all. 
Via The Motley Fool
News headline image
Moderna Science Day Highlights Expanding Potential of mRNA Platform
June 25, 2026
From Moderna, Inc.
Via ACCESS Newswire
News headline image
Therapeutics Stocks Q1 Teardown: BioMarin Pharmaceutical (NASDAQ:BMRN) Vs The Rest
June 24, 2026
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ... 
Via StockStory
Topics Artificial Intelligence
Which S&P500 stocks are moving on Tuesday? ↗
June 23, 2026
Via Chartmill
Explore the top gainers and losers within the S&P500 index in today's session. ↗
June 23, 2026
Via Chartmill
News headline image
Therapeutics Stocks Q1 Recap: Benchmarking Biogen (NASDAQ:BIIB)
June 22, 2026
Let’s dig into the relative performance of Biogen (NASDAQ:BIIB) and its peers as we unravel the now-completed Q1 therapeutics earnings season. Over the next ... 
Via StockStory
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap